GURUFOCUS.COM » STOCK LIST » Industrials » Industrial Products » Beyond Medical Technologies Inc (XCNQ:DOCT) » Definitions » Cyclically Adjusted FCF per Share

Beyond Medical Technologies (XCNQ:DOCT) Cyclically Adjusted FCF per Share : C$-0.53 (As of Mar. 2024)


View and export this data going back to 2008. Start your Free Trial

What is Beyond Medical Technologies Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Beyond Medical Technologies's adjusted free cash flow per share for the three months ended in Mar. 2024 was C$-0.006. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is C$-0.53 for the trailing ten years ended in Mar. 2024.

During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 59.50% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 44.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Beyond Medical Technologies was 59.50% per year. The lowest was 9.30% per year. And the median was 35.00% per year.

As of today (2024-06-11), Beyond Medical Technologies's current stock price is C$0.03. Beyond Medical Technologies's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was C$-0.53. Beyond Medical Technologies's Cyclically Adjusted Price-to-FCF of today is .


Beyond Medical Technologies Cyclically Adjusted FCF per Share Historical Data

The historical data trend for Beyond Medical Technologies's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beyond Medical Technologies Cyclically Adjusted FCF per Share Chart

Beyond Medical Technologies Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -9.43 -8.89 -4.85 -1.17 -0.59

Beyond Medical Technologies Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.11 -0.69 -0.64 -0.59 -0.53

Competitive Comparison of Beyond Medical Technologies's Cyclically Adjusted FCF per Share

For the Pollution & Treatment Controls subindustry, Beyond Medical Technologies's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Beyond Medical Technologies's Cyclically Adjusted Price-to-FCF Distribution in the Industrial Products Industry

For the Industrial Products industry and Industrials sector, Beyond Medical Technologies's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Beyond Medical Technologies's Cyclically Adjusted Price-to-FCF falls into.



Beyond Medical Technologies Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Beyond Medical Technologies's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.006/126.2576*126.2576
=-0.006

Current CPI (Mar. 2024) = 126.2576.

Beyond Medical Technologies Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 -0.053 99.473 -0.067
201409 -0.018 99.394 -0.023
201412 0.233 98.367 0.299
201503 0.048 99.789 0.061
201506 -0.410 100.500 -0.515
201509 -0.027 100.421 -0.034
201512 0.013 99.947 0.016
201603 -0.151 101.054 -0.189
201606 -0.202 102.002 -0.250
201609 0.057 101.765 0.071
201612 -0.025 101.449 -0.031
201703 -1.340 102.634 -1.648
201706 -0.142 103.029 -0.174
201709 0.000 103.345 0.000
201712 -0.348 103.345 -0.425
201803 -0.170 105.004 -0.204
201806 -0.112 105.557 -0.134
201809 -0.151 105.636 -0.180
201812 -0.133 105.399 -0.159
201903 -0.156 106.979 -0.184
201906 -0.218 107.690 -0.256
201909 -0.149 107.611 -0.175
201912 -0.093 107.769 -0.109
202003 -0.075 107.927 -0.088
202006 -0.180 108.401 -0.210
202009 -0.042 108.164 -0.049
202012 -0.107 108.559 -0.124
202103 -0.129 110.298 -0.148
202106 -0.041 111.720 -0.046
202109 -0.004 112.905 -0.004
202112 -0.026 113.774 -0.029
202203 -0.047 117.646 -0.050
202206 -0.018 120.806 -0.019
202209 -0.024 120.648 -0.025
202212 -0.031 120.964 -0.032
202303 -0.030 122.702 -0.031
202306 -0.018 124.203 -0.018
202309 -0.012 125.230 -0.012
202312 -0.007 125.072 -0.007
202403 -0.006 126.258 -0.006

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


Beyond Medical Technologies  (XCNQ:DOCT) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Beyond Medical Technologies Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of Beyond Medical Technologies's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Beyond Medical Technologies (XCNQ:DOCT) Business Description

Traded in Other Exchanges
Address
1055 West Georgia Street, Suite 1500, Vancouver, BC, CAN, V6H 1C3
Beyond Medical Technologies Inc is seeking to find new opportunities.
Executives
Bharat Bhushan Director